11h
BUCKSCO.Today on MSNMalvern’s Endo Enters Into Agreement to Merge with Mallinckrodt in $6 Billion DealMalvern-based Endo has agreed to merge with Mallinckrodt in a cash and stock deal, valuing the combined pharmaceutical ...
Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.
12d
MedPage Today on MSNFirst Generics for Low-Dose Rivaroxaban Get FDA ApprovalThe FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.
An analysis by Pharmarack, a market research firm, showed that 226 vildagliptin (anti-diabetic) brands are now available in ...
For what appears to be the first time, the FDA scolded a company for a promotional display that falsely claimed its ...
Type erasure in Java generics programming can cause a variety of problems in your code. Fortunately, there are ways to work ...
Empagliflozin, which in addition to treating type-2 diabetes, also aids weight loss, and reduces cardiovascular and kidney ...
A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...
The merger will give the combined entity the financial flexibility to pursue drug licensing deals and broaden its therapeutic ...
This dramatic disparity reveals how generics serve as the foundation of sustainable healthcare delivery to millions. Among the leaders in this vital industry stands Medochemie, a pharmaceutical ...
The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results